| Characterizing treatment pathways at scale using the OHDSI network G Hripcsak, PB Ryan, JD Duke, NH Shah, RW Park, V Huser, MA Suchard, ... Proceedings of the National Academy of Sciences 113 (27), 7329-7336, 2016 | 339 | 2016 |
| Feasibility and utility of applications of the common data model to multiple, disparate observational health databases EA Voss, R Makadia, A Matcho, Q Ma, C Knoll, M Schuemie, FJ DeFalco, ... Journal of the American Medical Informatics Association 22 (3), 553-564, 2015 | 249 | 2015 |
| Comparative effectiveness of canagliflozin, SGLT2 inhibitors and non‐SGLT2 inhibitors on the risk of hospitalization for heart failure and amputation in patients with type 2 … PB Ryan, JB Buse, MJ Schuemie, F DeFalco, Z Yuan, PE Stang, JA Berlin, ... Diabetes, Obesity and Metabolism 20 (11), 2585-2597, 2018 | 202 | 2018 |
| Risk of lower extremity amputations in people with type 2 diabetes mellitus treated with sodium‐glucose co‐transporter‐2 inhibitors in the USA: a retrospective cohort study Z Yuan, FJ DeFalco, PB Ryan, MJ Schuemie, PE Stang, JA Berlin, ... Diabetes, Obesity and Metabolism 20 (3), 582-589, 2018 | 117 | 2018 |
| Deep phenotyping of 34,128 adult patients hospitalised with COVID-19 in an international network study E Burn, SC You, AG Sena, K Kostka, H Abedtash, MTF Abrahão, ... Nature communications 11 (1), 5009, 2020 | 87 | 2020 |
| Incidence of diabetic ketoacidosis among patients with type 2 diabetes mellitus treated with SGLT2 inhibitors and other antihyperglycemic agents Y Wang, M Desai, PB Ryan, FJ DeFalco, MJ Schuemie, PE Stang, ... Diabetes research and clinical practice 128, 83-90, 2017 | 75 | 2017 |
| Multisite evaluation of a data quality tool for patient-level clinical data sets V Huser, FJ DeFalco, M Schuemie, PB Ryan, N Shang, M Velez, RW Park, ... EGEMs 4 (1), 2016 | 63 | 2016 |
| Increasing trust in real-world evidence through evaluation of observational data quality C Blacketer, FJ Defalco, PB Ryan, PR Rijnbeek Journal of the American Medical Informatics Association 28 (10), 2251-2257, 2021 | 58 | 2021 |
| Diabetic ketoacidosis in patients with type 2 diabetes treated with sodium glucose co‐transporter 2 inhibitors versus other antihyperglycemic agents: An observational study of … L Wang, EA Voss, J Weaver, L Hester, Z Yuan, F DeFalco, MJ Schuemie, ... Pharmacoepidemiology and drug safety 28 (12), 1620-1628, 2019 | 45 | 2019 |
| Treatment patterns and sequences of pharmacotherapy for patients diagnosed with depression in the United States: 2014 through 2019 DM Kern, MS Cepeda, F Defalco, M Etropolski BMC psychiatry 20, 1-10, 2020 | 38 | 2020 |
| An international characterisation of patients hospitalised with COVID-19 and a comparison with those previously hospitalised with influenza E Burn, SC You, AG Sena, K Kostka, H Abedtash, MTF Abrahao, ... MedRxiv, 2020 | 29 | 2020 |
| Deep phenotyping of 34,128 patients hospitalised with COVID-19 and a comparison with 81,596 influenza patients in America, Europe and Asia: an international network study E Burn, SC You, AG Sena, K Kostka, H Abedtash, MTF Abrahão, ... medRxiv, 2020.04. 22.20074336, 2020 | 28 | 2020 |
| Unraveling COVID-19: a large-scale characterization of 4.5 million COVID-19 cases using CHARYBDIS K Kostka, T Duarte-Salles, A Prats-Uribe, AG Sena, A Pistillo, S Khalid, ... Clinical Epidemiology, 369-384, 2022 | 27 | 2022 |
| Applying standardized drug terminologies to observational healthcare databases: a case study on opioid exposure FJ DeFalco, PB Ryan, M Soledad Cepeda Health Services and Outcomes Research Methodology 13, 58-67, 2013 | 23 | 2013 |
| Risk prediction for ischemic stroke and transient ischemic attack in patients without atrial fibrillation: a retrospective cohort study Z Yuan, EA Voss, FJ DeFalco, G Pan, PB Ryan, D Yannicelli, C Nessel Journal of Stroke and Cerebrovascular Diseases 26 (8), 1721-1731, 2017 | 14 | 2017 |
| Reopening businesses and risk of COVID-19 transmission A O’Donoghue, T Dechen, W Pavlova, M Boals, G Moussa, M Madan, ... NPJ digital medicine 4 (1), 51, 2021 | 13* | 2021 |
| Genomic identification of the TOR signaling pathway as a target of the plant alkaloid antofine in the phytopathogen Fusarium graminearum C Mogg, C Bonner, L Wang, J Schernthaner, M Smith, D Desveaux, ... Mbio 10 (3), 10.1128/mbio. 00792-19, 2019 | 13 | 2019 |
| Baseline phenotype and 30-day outcomes of people tested for COVID-19: an international network cohort including> 3.32 million people tested with real-time PCR and> 219,000 … A Golozar, LYH Lai, AG Sena, D Vizcaya, LM Schilling, V Huser, F Nyberg, ... medRxiv, 2020 | 11 | 2020 |
| Risk of lower extremity amputations in patients with type 2 diabetes mellitus treated with SGLT2 inhibitors in the United States: a retrospective cohort study Z Yuan, FJ Defalco, PB Ryan, MJ Schuemie, PE Stang, JA Berlin, M Desai, ... Diabetes Obes Metab 20 (3), 582-589, 2018 | 11 | 2018 |
| Phenotype algorithms for the identification and characterization of vaccine-induced thrombotic thrombocytopenia in real world data: a multinational network cohort study A Shoaibi, GA Rao, EA Voss, A Ostropolets, MA Mayer, ... Drug Safety 45 (6), 685-698, 2022 | 10 | 2022 |
Patrick RyanJanssen Research and DevelopmentVerified email at cornell.edu
